We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+32.61%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$610M
AUM Growth
+$17.3M
(+2.9%)
Cap. Flow
-$82.5M
Cap. Flow
% of AUM
-13.54%
Top 10 Holdings %
Top 10 Hldgs %
9.29%
Holding
412
New
138
Increased
22
Reduced
119
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Impinj
PI
|
+$3.89M |
| 2 |
KZR
Kezar Life Sciences
KZR
|
+$3.86M |
| 3 |
PENG
Penguin Solutions Inc
PENG
|
+$3.7M |
| 4 |
Forward Air
FWRD
|
+$3.51M |
| 5 |
Rambus
RMBS
|
+$3.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OptimizeRx
OPRX
|
+$7.23M |
| 2 |
PLXP
PLx Pharma Inc. Common Stock
PLXP
|
+$7.18M |
| 3 |
PAVmed
PAVM
|
+$6.57M |
| 4 |
EVRI
Everi Holdings
EVRI
|
+$4.68M |
| 5 |
Celldex Therapeutics
CLDX
|
+$4.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Industrials | 18.61% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Lee Enterprises
LEE
$181M
| $1.34M | 0.22% |
+38,855
| New | +$986K |
|
227
Crocs
CROX
$6.59B
| $1.34M | 0.22% |
10,424
-9,687
| -48% | -$1.49M |
|
228
Steven Madden
SHOO
$3.54B
| $1.34M | 0.22% |
+28,759
| New | +$1.32M |
|
229
Manhattan Associates
MANH
$11.3B
| $1.33M | 0.22% |
8,526
-5,837
| -41% | -$948K |
|
|
STRR
230
Star Equity Holdings
STRR
$42.4M
| $1.32M | 0.22% |
+45,932
| New | +$1.04M |
|
231
Quest Resource Holding
QRHC
$29.3M
| $1.31M | 0.22% |
189,398
-46,309
| -20% | -$278K |
|
232
Smith-Midland
SMID
$149M
| $1.31M | 0.22% |
+27,918
| New | +$780K |
|
233
Magnolia Oil & Gas
MGY
$5.86B
| $1.31M | 0.21% |
69,316
-22,358
| -24% | -$444K |
|
|
SI
234
DELISTED
Silvergate Capital Corporation
SI
| $1.3M | 0.21% |
+8,799
| New | +$1.5M |
|
|
TRT
235
Trio-Tech International
TRT
$110M
| $1.3M | 0.21% |
+194,040
| New | +$699K |
|
236
Esquire Financial Holdings
ESQ
$1.13B
| $1.3M | 0.21% |
+41,026
| New | +$1.33M |
|
|
CERE
237
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.29M | 0.21% |
39,907
-10,411
| -21% | -$367K |
|
238
Rapid7
RPD
$732M
| $1.29M | 0.21% |
10,927
-13,326
| -55% | -$1.64M |
|
239
Inspired Entertainment
INSE
$171M
| $1.27M | 0.21% |
98,407
-2,946
| -3% | -$38.9K |
|
240
DigitalOcean
DOCN
$14.8B
| $1.27M | 0.21% |
15,802
-5,958
| -27% | -$558K |
|
241
Kadant
KAI
$4B
| $1.26M | 0.21% |
5,474
-2,590
| -32% | -$577K |
|
242
Vista Energy
VIST
$7.29B
| $1.25M | 0.21% |
+235,414
| New | +$1.36M |
|
243
Workiva
WK
$3.52B
| $1.25M | 0.21% |
9,612
-10,723
| -53% | -$1.51M |
|
244
Shutterstock
SSTK
$221M
| $1.25M | 0.21% |
11,286
-208
| -2% | -$24.2K |
|
245
Capital Bancorp
CBNK
$609M
| $1.25M | 0.2% |
47,503
-1,392
| -3% | -$36.2K |
|
|
CCRN
246
DELISTED
Cross Country Healthcare
CCRN
| $1.23M | 0.2% |
44,293
-48,218
| -52% | -$1.17M |
|
247
Matador Resources
MTDR
$6B
| $1.23M | 0.2% |
33,219
-23,479
| -41% | -$961K |
|
|
ZUO
248
DELISTED
Zuora, Inc.
ZUO
| $1.21M | 0.2% |
+64,568
| New | +$1.3M |
|
|
SGMA
249
DELISTED
Sigmatron International
SGMA
| $1.18M | 0.19% |
114,596
-3,376
| -3% | -$32.5K |
|
|
APEN
250
DELISTED
Apollo Endosurgery, Inc.
APEN
| $1.18M | 0.19% |
139,564
-70,142
| -33% | -$613K |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q4 2021 Portfolio in Review
As of Q4 2021, EAM Investors held 412 positions worth $610M, up 2.9% from $593M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
EAM Investors withdrew a net $82.5M in Q4 2021, closing 133 positions and reducing 119 holdings. Its most notable exit was OptimizeRx, an estimated $7.23M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, EAM Investors opened a new position in Impinj worth $4.76M.
- EAM Investors's largest Q4 2021 buy was Impinj: 53,617 shares worth $4.76M.
- EAM Investors added most to BlueLinx in Q4 2021, an estimated $2.56M increase.
- EAM Investors's biggest Q4 2021 reduction was Aehr Test Systems, cutting an estimated $3.65M.
- EAM Investors fully exited OptimizeRx in Q4 2021, selling an estimated $7.23M.
- EAM Investors's ten largest holdings make up 9.3% of its $610M portfolio in Q4 2021.
- EAM Investors opened 138 new positions and closed 133 in Q4 2021.
- EAM Investors's portfolio value rose 2.9% quarter-over-quarter to $610M.
Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.